Foodborne Diseases Active Surveillance Network (FoodNet)
FoodCORE - Foodborne Diseases Centers for Outbreak Response Enhancement
FoodCORE-Foodborne Diseases Centers for Outbreak Response Enhancement-began as a CDC funded pilot project in 2009 in three sites to improve state and local hth department responses to foodborne disease outbreaks. It was so successful that the project currently fully or partially funds 7 sites, encompassing approximately 15% of the US population. FoodCORE sites are working together to develop new and better methods to detect, investigate, respond to, and control multistate outbreaks of foodborne diseases. Although efforts are primarily focused on outbreaks caused by bacteria including Salmonella, Shiga toxin-producing Escherichia coli (STEC) and Listeria, the ability to detect and investigate viral and parasitic foodborne disease outbreaks will also be enhanced and strengthened.
Influenza Hospitalization Surveillance
The Connecticut EIP conducts active surveillance for laboratory-confirmed, influenza-associated hospitalizations. The 2012-13 season marks the tenth consecutive year of data collection. Laboratory-confirmed influenza is reportable to the Connecticut Department of Public Health (CTDPH). Hospitalized influenza is also a reportable condition in Connecticut. EIP staff work with CTDPH, CDC, and hospital infection preventionists to conduct surveillance for hospitalized cases of influenza among residents of Middlesex and New Haven Counties.
Human Papillomavirus Vaccine Impact Monitoring Project Across CT (HPV-IMPACT)
Clostridium difficile (C. difficile) Surveillance
Tick-Borne Diseases Network (TickNET)
Effectiveness of Rotavirus Vaccine in Preventing Hospitalization in Young Children
The initial landmark trials of Rotateq and Rotarix—rotavirus vaccines approved for widespread use in 2006 and 2008, respectively—revealed impressive efficacy and safety profiles from a large cohort of various countries, as well as a reduction in rates of hospitalizations, and emergency room and office visits. However, none of these studies were conducted in the United States. Accordingly, this study’s primary aim is to assess the effectiveness of the recently licensed rotavirus vaccines in preventing hospitalization, and emergency room and office visits, in young children specifically in a US clinical setting. This study will provide a generalizable model and better understanding of the vaccines’ effectiveness in the current setting of the US health care system.
